Home > > > > Report Detail

Investigation Report on China Simvastatin Market, 2010-2019

Publisher Name :
Date: 25-Jun-2015
No. of pages: 40

Lyperlipidemia, a common disease in present society, has become one of the three health killers with an increasing incidence. Lyperlipidemia can lead to atherosclerosis, coronary heart disease, stroke, myocardial infarction, hemiplegia and so on. Besides, a high level of blood fat will induce such severe diseases as hypertension, hyperglycemia, fatty liver, pancreatitis and fundus hemorrhage which not only cause serious damage but also influence patients' life quality.

With the sustained economic development and the improvements in diet, Chinese people's blood fat level rises too. Many local epidemiological studies on blood fat have proved that a conservative estimate of the incidence of hyperlipemia is 7%8% while the actual incidence might be above 10%. Over 100 million people in China have to receive cholesterollowering therapy, more so with the coming ageing society. As people increasingly pay attention to health, cholesterollowering drugs will become more and more promising. The annual market size of statin drug is estimated to surpass USD 20 billion around the world, growing at an annual rate of 20% .

Simvastatin, a new generation of HMGCOA reductase inhibitor produced by restructuring lovastatin, was introduced into China by MSD (China) in 1995. Domestic simvastatin was developed by Sichuan Industrial Institute of Antibiotics. Simvastatin develops fast after entering China, sales value being CNY 104 million in 2005 and CNY 197 million in 2010. However, later, its sales began to drop to CNY 156 million in 2014. Hangzhou MSD Pharmaceutical Co., Ltd, Merck Sharp & Dohme (UK), Guangzhou Nanxin Pharmaceutical Co., Ltd, Sichuan Hairong Pharmaceutical Co., Ltd and Shandong Lukang Pharmaceutical Co., Ltd occupy the majority of market, among which Hangzhou MSD Pharmaceutical Co., Ltd has the largest market share of 39% for sales value in 2014.

The sales value of simvastatin will stay at a certain level in a given period despite a downtrend in recent years.

Readers can get at least the following information from this report:


  • market size of simvastatin in China

  • price of simvastatin in China

  • market outlook of simvastatin in China


The author suggests the following groups of people purchase this report:


  • manufacturers of lipidlowering drugs

  • investors/ research institutions interested in Chinese medicine market

  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Investigation Report on China Simvastatin Market, 2010-2019

Table of Contents

1 Related Concepts of Simvastatin
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Simvastatin in China
2.1 Patent and Approval Status of Simvastatin in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of Simvastatin in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Manufacturers of Simvastatin in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Survey on Dosage Forms of Simvastatin in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 Reference Price of Simvastatin in Chinese Hospitals in 2014
6.1 Hangzhou MSD Pharmaceutical Co., Ltd (Trade Name: Shujiangzhi)
6.2 Sichuan Hairong Pharmaceutical Co., Ltd (Trade Name: Xindasu)
6.3 Shandong Lukang Pharmaceutical Co., Ltd (Trade Name: Xinglu)
6.4 Guangzhou Nanxin Pharmaceutical Co., Ltd (Trade Name: Simcor)
6.5 Cinmed Pharmaceuticals CP (Trade Name: Jianzhiting)
6.6 Merck Sharp & Dohme (UK) (Trade Name: Zocor)

7 Major Manufacturers of Simvastatin in Chinese Market, 2010-2014
7.1 Cinmed Pharmaceuticals CP
7.2 Guangzhou Nanxin Pharmaceutical Co., Ltd
7.3 Shandong Lukang Pharmaceutical Co., Ltd
7.4 Sichuan Hairong Pharmaceutical Co., Ltd
7.5 Merck Sharp & Dohme

8 Market Outlook of Simvastatin in China, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

List of Charts

Chart Patent Status of Simvastatin in China
Chart Approval Information of Simvastatin in China
Chart Sales Status of Simvastatin in China
Chart Sales Value of Simvastatin in China, 2010-2014
Chart Sales Value of Simvastatin in Some Regions in China, 2010-2014
Chart Sales Volume of Simvastatin in China, 2010-2014
Chart Sales Volume of Simvastatin in Some Regions in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Simvastatin for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Simvastatin Made by Hangzhou MSD in China, 2010-2014
Chart Sales Value and Market Share of Simvastatin Made by Merck Sharp & Dohme (UK) in China, 2010-2014
Chart Sales Value and Market Share of Simvastatin Made by Guangzhou Nanxin in China, 2010-2014
Chart Sales Value and Market Share of Simvastatin Made by Cinmed in China, 2010-2014
Chart Sales Value and Market Share of Simvastatin Made by Shandong Lukang Pharmaceutical in China, 2010-2014
Chart Sales Value and Market Share of Simvastatin Pills in China, 2010-2014
Chart Sales Value and Market Share of Simvastatin Tablets in China, 2010-2014
Chart Sales Value and Market Share of Simvastatin Capsules in China, 2010-2014
Chart Price of Simvastatin Made by Hangzhou MSD Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Simvastatin Made by Sichuan Hairong Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Simvastatin Made by Shandong Lukang Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Simvastatin Made by Guangzhou Nanxin Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Simvastatin Made by Cinmed Pharmaceuticals CP in Some Chinese Cities in 2014
Chart Price of Simvastatin Made by Merck Sharp & Dohme (UK) in Some Chinese Cities in 2014

  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs